Alzheimer’s Association to Fund Dementia Risk Reduction Trial Mike Splaine reports from #AAIC2017 in London on the news of the Alzheimer’s Association’s $20 million lifestyle intervention trial in the U.S. to prevent cognitive decline: “This announcement continues and extends the trend of public health and the Alzheimer community to move forward swiftly on the evidence… Continue reading Splaine Consulting Updates: July 2017
Catch up on the latest international Alzheimer advocacy activities from Splaine Consulting.
A huge step forward for Global Alzheimer Advocacy GENEVA, SWITZERLAND—On Monday, May 29th, the World Health Organization (WHO) Assembly officially passed a Global Action Plan on Dementia, representing a huge step forward for Alzheimer advocacy around the world. Areas for action include: reducing the risk of dementia; diagnosis, treatment and care; research and innovative technologies;… Continue reading Splaine Consulting Updates: May 2017
PAHO and Alzheimer’s University Training March was a busy month, with Mike Splaine and Kate Gordon presenting a 4-day training course, Alzheimer’s University, for national leaders of Alzheimer’s associations with Alzheimer’s Disease International. Training events included a visit to the Pan American Health Organization (PAHO) to discuss the implementation of the PAHO Regional Plan of Action on Dementia in Older Adults. A… Continue reading Splaine Consulting Updates: April 2017